Novel antimicrobial peptides against Cutibacterium acnes designed by deep learning.

Journal: Scientific reports
PMID:

Abstract

The increasing prevalence of antibiotic resistance in Cutibacterium acnes (C. acnes) requires the search for alternative therapeutic strategies. Antimicrobial peptides (AMPs) offer a promising avenue for the development of new treatments targeting C. acnes. In this study, to design peptides with the specific inhibitory activity against C. acnes, we employed a deep learning pipeline with generators and classifiers, using transfer learning and pretrained protein embeddings, trained on publicly available data. To enhance the training data specific to C. acnes inhibition, we constructed a phylogenetic tree. A panel of 42 novel generated linear peptides was then synthesized and experimentally evaluated for their antimicrobial selectivity and activity. Five of them demonstrated their high potency and selectivity against C. acnes with MIC of 2-4 µg/mL. Our findings highlight the potential of these designed peptides as promising candidates for anti-acne therapeutics and demonstrate the power of computational approaches for the rational design of targeted antimicrobial peptides.

Authors

  • Qichang Dong
    Shanghai MetaNovas Biotech Co., Ltd, Shanghai, 200120, China.
  • Shaohua Wang
    Shanghai MetaNovas Biotech Co., Ltd, Shanghai, 200120, China.
  • Ying Miao
    College of Biological Science and Engineering, Fuzhou University, Fuzhou, 350108, China.
  • Heng Luo
    Center for Computational Health, IBM T.J. Watson Research Center, 1101 Kitchawan Road, Yorktown Heights, NY, USA.
  • Zuquan Weng
    The Centre for Big Data Research in Burns and Trauma, Fuzhou University, Fujian Province, China.
  • Lun Yu
    Metanovas Biotech Inc., Foster City, 94404, USA. lunyu@metanovas.com.